Td Asset Management Inc Dr Reddys Laboratories LTD Transaction History

Td Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$57.98 - $73.08 $574,002 - $723,492	-9,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$62.61 - $71.29 $619,839 - $705,771	9,900 New	9,900 $706,000
Q3 2020 Nov 10, 2020	SELL	$51.39 - $72.41 $919,881 - $1.3 Million	-17,900 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$39.55 - $54.65 $1.08 Million - $1.49 Million	-27,200 Reduced 60.31%	17,900 $949,000
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $3.22 Million - $4.25 Million	-92,800 Reduced 67.3%	45,100 $1.82 Million
Q1 2019 May 08, 2019	BUY	$35.77 - $40.57 $4.58 Million - $5.2 Million	128,100 Added 1307.14%	137,900 $5.59 Million
Q4 2018 Feb 01, 2019	BUY	$31.89 - $38.44 $312,522 - $376,712	9,800 New	9,800 $369,000

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.